Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Mark Peterson CPA who wrote (533)	2/9/1999 9:33:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 942

Report on the Merrill Lynch conference from labpuppy.com: Warner-Lambert (WLA) They could not comment on the Agouron deal as it has not closed yet. They will start a direct-to-consumer advertising campaign for Lipitor shortly. On March 26, the FDA will have an advisory meeting to go over Rezulin's marketing data. New competition for Rezulin will hit the market in the 3Q of 1999 (from SmithKline Beecham) and 2000 (from Eli Lilly). They wouldn't say more than they are negotiating with Pfizer regarding a co-promotion product (as a result of giving Pfizer co-promotion rights to Lipitor). labpuppy.com